IHE vs. UTES
IHE (iShares U.S. Pharmaceuticals ETF) and UTES (Virtus Reaves Utilities ETF) are both exchange-traded funds - IHE is a Health & Biotech Equities fund tracking the Dow Jones U.S. Select Pharmaceuticals Index, while UTES is a Utilities Equities fund actively managed by Virtus Investment Partners. IHE is passively managed, while UTES is actively managed. Over the past 10 years, IHE returned 7.81%/yr vs 12.40%/yr for UTES. At a 0.28 correlation, their price movements are largely independent. IHE charges 0.42%/yr vs 0.49%/yr for UTES.
Performance
IHE vs. UTES - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IHE achieves a 6.47% return, which is significantly higher than UTES's 0.08% return. Over the past 10 years, IHE has underperformed UTES with an annualized return of 7.81%, while UTES has yielded a comparatively higher 12.40% annualized return.
IHE
- 1D
- 1.16%
- 1M
- 1.80%
- YTD
- 6.47%
- 6M
- 8.51%
- 1Y
- 40.15%
- 3Y*
- 17.47%
- 5Y*
- 9.98%
- 10Y*
- 7.81%
UTES
- 1D
- -0.98%
- 1M
- -6.58%
- YTD
- 0.08%
- 6M
- -1.81%
- 1Y
- 7.86%
- 3Y*
- 22.78%
- 5Y*
- 15.66%
- 10Y*
- 12.40%
IHE vs. UTES - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IHE iShares U.S. Pharmaceuticals ETF | 6.47% | 31.69% | 8.13% | 1.06% | -4.87% | 13.07% | 13.66% | 15.47% | -7.76% | 10.64% |
UTES Virtus Reaves Utilities ETF | 0.08% | 25.71% | 45.35% | -2.46% | 0.80% | 20.74% | -0.30% | 25.48% | 5.14% | 14.21% |
Correlation
The correlation between IHE and UTES is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.11 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.26 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.36 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.31 |
Correlation (All Time) Calculated using the full available price history since Sep 25, 2015 | 0.28 |
The correlation between IHE and UTES shifts across timeframes, from 0.11 (1 year) to 0.36 (5 years), reflecting how their relationship changes across market environments.
IHE vs. UTES - Sectors Allocation Comparison
Sectors
IHE
UTES
Healthcare
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
Healthcare
IHE
UTES
-
Basic Materials
IHE
-
UTES
-
Communication Services
IHE
-
UTES
-
Consumer Cyclical
IHE
-
UTES
-
Consumer Defensive
IHE
-
UTES
-
Energy
IHE
-
UTES
-
Financial Services
IHE
-
UTES
-
Industrials
IHE
-
UTES
-
Real Estate
IHE
-
UTES
-
Technology
IHE
-
UTES
-
Utilities
IHE
-
UTES
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IHE vs. UTES — Risk / Return Rank
IHE
UTES
IHE vs. UTES - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares U.S. Pharmaceuticals ETF (IHE) and Virtus Reaves Utilities ETF (UTES). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IHE | UTES | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.99 | ||
| Sortino ratioReturn per unit of downside risk | +2.79 | ||
| Omega ratioGain probability vs. loss probability | 1.40 | 1.08 | +0.32 |
| Calmar ratioReturn relative to maximum drawdown | 4.76 | 0.57 | +4.19 |
| Martin ratioReturn relative to average drawdown | 14.35 | 1.30 | +13.05 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| IHE | UTES | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.36 | 0.37 | +1.99 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.62 | 0.76 | -0.15 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.43 | 0.62 | -0.18 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.51 | 0.70 | -0.19 |
Drawdowns
IHE vs. UTES - Drawdown Comparison
The maximum IHE drawdown since its inception was -38.20%, which is greater than UTES's maximum drawdown of -35.39%. Use the drawdown chart below to compare losses from any high point for IHE and UTES.
Loading charts...
Drawdown Indicators
| IHE | UTES | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -38.20% | -35.39% | -2.81% |
Max Drawdown (1Y)Largest decline over 1 year | -8.47% | -13.88% | +5.41% |
Max Drawdown (3Y)Largest decline over 3 years | -15.92% | -17.62% | +1.70% |
Max Drawdown (5Y)Largest decline over 5 years | -16.03% | -20.40% | +4.37% |
Max Drawdown (10Y)Largest decline over 10 years | -29.59% | -35.39% | +5.80% |
Current DrawdownCurrent decline from peak | -2.80% | -9.26% | +6.46% |
Average DrawdownAverage peak-to-trough decline | -7.92% | -5.52% | -2.40% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 2.81% | 6.08% | -3.27% |
Volatility
IHE vs. UTES - Volatility Comparison
The current volatility for iShares U.S. Pharmaceuticals ETF (IHE) is 5.53%, while Virtus Reaves Utilities ETF (UTES) has a volatility of 7.40%. This indicates that IHE experiences smaller price fluctuations and is considered to be less risky than UTES based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IHE | UTES | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.53% | 7.40% | -1.87% |
Volatility (6M)Calculated over the trailing 6-month period | 12.48% | 16.95% | -4.47% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.07% | 21.27% | -4.20% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.24% | 20.60% | -4.36% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.05% | 20.16% | -2.11% |
IHE vs. UTES - Expense Ratio Comparison
IHE has a 0.42% expense ratio, which is lower than UTES's 0.49% expense ratio.
Dividends
IHE vs. UTES - Dividend Comparison
IHE's dividend yield for the trailing twelve months is around 1.65%, more than UTES's 1.50% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IHE iShares U.S. Pharmaceuticals ETF | 1.65% | 1.76% | 1.73% | 1.39% | 2.01% | 1.49% | 1.19% | 1.40% | 1.25% | 1.36% | 0.92% | 1.93% |
UTES Virtus Reaves Utilities ETF | 1.50% | 1.42% | 1.51% | 2.44% | 2.13% | 1.94% | 2.09% | 1.84% | 2.09% | 3.44% | 3.53% | 0.61% |
Frequently Asked Questions
IHE and UTES have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
UTES has higher volatility (7.40%) compared to IHE (5.53%). In terms of maximum drawdown, IHE dropped -38.20% vs UTES's -35.39%.
On 10-year performance, UTES leads with 12.40% vs 7.81% for IHE. On fees, IHE is cheaper at 0.42% per year. On volatility, IHE has been the lower-risk option at 5.53%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, UTES has performed better with a 12.40% return vs 7.81%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IHE is cheaper with a 0.42% expense ratio, compared with 0.49% for UTES.
IHE has the higher dividend yield at 1.65%, compared with 1.50% for UTES.
IHE is categorized as Health & Biotech Equities, while UTES is Utilities Equities. They also come from different issuers: iShares and Virtus Investment Partners. Their fees differ too: 0.42% for IHE and 0.49% for UTES.
IHE currently has the higher Sharpe Ratio (2.36 vs 0.37), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IHE and UTES
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer